Page last updated: 2024-09-03
2-chloro-n(6)cyclopentyladenosine and pinacidil
2-chloro-n(6)cyclopentyladenosine has been researched along with pinacidil in 1 studies
Compound Research Comparison
| Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (pinacidil) | Trials (pinacidil) | Recent Studies (post-2010) (pinacidil) |
|---|---|---|---|---|---|
| 252 | 0 | 43 | 1,059 | 41 | 125 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davie, CS; Everitt, DE; Standen, NB | 1 |
Other Studies
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and pinacidil
| Article | Year |
|---|---|
Increase in the vasorelaxant potency of K(ATP) channel opening drugs by adenosine A(1) and A(2) receptors in the pig coronary artery.
Topics: Adenosine; Animals; ATP-Binding Cassette Transporters; Coronary Vessels; Cromakalim; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; KATP Channels; Nicorandil; Phenethylamines; Pinacidil; Potassium Channels; Potassium Channels, Inwardly Rectifying; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Swine; Triazines; Triazoles; Vasodilator Agents; Xanthines | 1999 |